NERv Technology raises $3.32 million as it prepares to bring medical sensor tech to market
NERv Technology, a Kitchener-Waterloo-based startup offering a sensory platform designed for the healthtech sector, has closed a $3.32 million CAD ($2.65 million USD) seed round of funding. NERv has been able to grow its team from 16 at the start of the pandemic to 24.
The seed round was led by returning investor SOSV, with participation from Graphene Ventures, OneValley, Northspring Capital Partners, Boutique Venture Partners, and Threshold Impact. A number of additional undisclosed strategic investors, angels, and physicians also invested in the round.
NERv has developed a sensory device that is aimed to help doctors monitor postoperative patients remotely, by detecting potential complications. The startup’s device can attach to catheters and wound drains, and detects leakages that can lead to critical, sometimes fatal, complications.